✦ LIBER ✦

A Phase II Trial of Gemcitabine Plus Capecitabine for Metastatic Renal Cell Cancer Previously Treated With Immunotherapy and Targeted Agents

✍ Scribed by Tannir, Nizar M.; Thall, Peter F.; Ng, Chaan S.; Wang, Xuemei; Wooten, Leiko; Siefker-Radtke, Arlene; Mathew, Paul; Pagliaro, Lance; Wood, Christopher; Jonasch, Eric

Book ID: 122474845
Publisher: Lippincott Williams and Wilkins
Year: 2008
Tongue: English
Weight: 118 KB
Volume: 180
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2008.05.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Trial of Weekly Intravenous Gem

Phase II Trial of Weekly Intravenous Gemcitabine Administration With Interferon and Interleukin-2 Immunotherapy for Metastatic Renal Cell Cancer

✍ Neri, B.; Doni, L.; Gemelli, M.T.; Fulignati, C.; Turrini, M.; Di Cello, V.; Dom 📂 Article 📅 2002 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 118 KB

A Phase II Trial of Gemcitabine in Patie

A Phase II Trial of Gemcitabine in Patients with Metastatic Breast Cancer Previously Treated with an Anthracycline and Taxane

✍ Shanu Modi; Violante E. Currie; Andrew D. Seidman; Ariadne M. Bach; Katherine S. 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 868 KB

A phase II trial of erlotinib in combina

A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational research

✍ Do-Youn Oh, Keun Wook Lee, Kyung-Hee Lee, Chang-Hak Sohn, Young Suk Park, Dae Yo 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 224 KB

A phase I clinical trial of low-dose int

A phase I clinical trial of low-dose interferon-α-2A, thalidomide plus gemcitabine and capecitabine for patients with progressive metastatic renal cell carcinoma

✍ Robert J. Amato; Muhammad Khan 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 221 KB

Phase II Trial of Capecitabine and Weekl

Phase II Trial of Capecitabine and Weekly Paclitaxel in Patients with Metastatic Breast Cancer Previously Treated with Every-3-Week Taxane Therapy

✍ Joanne L. Blum; E. Claire Dees; Svetislava J. Vukelja; Mammo Amare; David P. Gil 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 111 KB

A Phase II trial of the combination of v

A Phase II trial of the combination of vinorelbine and capecitabine as second-line treatment in metastatic breast cancer previously treated with taxanes and/or anthracyclines

✍ George Orphanos; Athanasios Alexopoulos; Savvoula Malliou; George Ioannidis; Ale 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 312 KB